AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The technology’s potential to transform trials will need to be balanced with the challenge of instilling trust in ...

Key Takeaways AI accelerates drug approvals in 2025 by streamlining clinical data analysis.Advanced AI tools reduce costs and time for new medicine development.

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

The American Medical Association has adopted a new policy that calls for clinical AI tools that can explain their answers. It ...

Chemotherapy is a vital treatment for people with all forms of cancer. It's a process that uses drugs designed to kill, ...

Tempus will use its "Lens" data analytics platform to analyze and restructure genomic data from the the Abrams Research Center.

The American Medical Association has established a new policy that aims to increase transparency and trust in AI tools used in clinical care. The policy was approved during the AMA’s annual meeting ...

Parshv Gala's AI-powered AllayCare app is revolutionizing mental health diagnosis, enabling early detection, reducing ...

Highlight brain imaging analysis solutions, including 'Neurophet AQUA AD', which monitors side effects from Alzheimer's disease treatments; To accelerate partnering efforts with g ...

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients.

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...